Top

Current Cardiology Reports

Published in:

29-06-2022 | Aortic Valve Replacement | Valvular Heart Disease (TL Kiefer, Section Editor)

Update on Minimalist TAVR Care Pathways: Approaches to Care in 2022

Authors: Mariem A. Sawan, Avery E. Calhoun, Kendra J. Grubb, Chandan M. Devireddy

Published in: Current Cardiology Reports | Issue 9/2022

Abstract

Purpose of Review

This review summarizes current data supporting a minimalist TAVR approach and identifies the need for additional study to optimize TAVR care. The authors discuss future directions of the TAVR landscape and how this necessitates evolution of minimalist care pathways.

Recent Findings

Transcatheter aortic valve replacement (TAVR) has become a mainstay in the treatment of aortic stenosis since the initial procedure in 2002. Recently, attention has shifted to TAVR optimization and the minimalist approach with a focus on minimizing procedural sedation, protocolization of perioperative management, and prioritization on early discharge. This approach has been shown to be safe and reduce procedure time, length of stay, and overall cost for hospital systems.

Summary

The minimalist care pathway avoids general anesthesia, shortens procedure time and length of stay, and reduces cost without changing mortality or readmission rates at 30 days. A variety of protocols have been proposed without a clear consensus on specific components or patient eligibility. There is a continued need for data regarding patient risk stratification, valve selection, and discharge strategy as TAVR becomes increasingly common.

Carroll JD, Mack MJ, Vemulapalli S, Herrmann HC, Gleason TG, Hanzel G, et al. STS-ACC TVT Registry of Transcatheter Aortic Valve Replacement. J Am Coll Cardiol. 2020;76:2492–516. https://doi.org/10.1016/j.jacc.2020.09.595.CrossRefPubMed

Kamioka N, Wells J, Keegan P, Lerakis S, Binongo J, Corrigan F, et al. Predictors and Clinical Outcomes of Next-Day Discharge After Minimalist Transfemoral Transcatheter Aortic Valve Replacement. JACC Cardiovasc Interv. 2018;11:107–15. https://doi.org/10.1016/j.jcin.2017.10.021.CrossRefPubMed

Fröhlich GM, Lansky AJ, Webb J, Roffi M, Toggweiler S, Reinthaler M, et al. Local versus general anesthesia for transcatheter aortic valve implantation (TAVR)–systematic review and meta-analysis. BMC Med. 2014;12:41. https://doi.org/10.1186/1741-7015-12-41.CrossRefPubMedPubMedCentral

Sammour Y, Kerrigan J, Banerjee K, Gajulapalli RD, Lak H, Chawla S, et al. Comparing outcomes of general anesthesia and monitored anesthesia care during transcatheter aortic valve replacement: The Cleveland Clinic Foundation experience. Catheter Cardiovasc Interv. 2021;98:E436–43. https://doi.org/10.1002/ccd.29496.CrossRefPubMed

Hosoba S, Yamamoto M, Shioda K, Sago M, Koyama Y, Shimura T, et al. Safety and efficacy of minimalist approach in transfemoral transcatheter aortic valve replacement: insights from the Optimized transCathEter vAlvular interventioN-Transcatheter Aortic Valve Implantation (OCEAN-TAVI) registry. Interact Cardiovasc Thorac Surg. 2018;26:420–4. https://doi.org/10.1093/icvts/ivx355.CrossRefPubMed

Droppa M, Borst O, Katzenberger T, Krause R, Grasshoff C, Gawaz M, et al. Comparison of safety and periprocedural complications of transfemoral aortic valve replacement under local anaesthesia: minimalist versus complete Heart Team. EuroIntervention. 2019;14:e1819–25. https://doi.org/10.4244/EIJ-D-18-00795.CrossRefPubMed

Moriyama N, Vento A, Laine M. Safety of Next-Day Discharge After Transfemoral Transcatheter Aortic Valve Replacement With a Self-Expandable Versus Balloon-Expandable Valve Prosthesis. Circ Cardiovasc Interv. 2019;12: e007756. https://doi.org/10.1161/CIRCINTERVENTIONS.118.007756.CrossRefPubMed

Feistritzer HJ, Kurz T, Stachel G, Hartung P, Lurz P, Eitel I, et al. SOLVE-TAVI Investigators. Impact of Anesthesia Strategy and Valve Type on Clinical Outcomes After Transcatheter Aortic Valve Replacement. J Am Coll Cardiol. 2021;77:2204–2215. https://doi.org/10.1016/j.jacc.2021.03.007.

Konigstein M, Ben-Shoshan J, Zahler D, Flint N, Margolis G, Granot Y, et al. Outcome of patients undergoing TAVR with and without the attendance of an anesthesiologist. Int J Cardiol. 2017;241:124–7. https://doi.org/10.1016/j.ijcard.2017.01.154.CrossRefPubMed

10.

•• Wood DA, Lauck SB, Cairns JA, Humphries KH, Cook R, Welsh R, et al. The Vancouver 3M (Multidisciplinary, Multimodality, But Minimalist) Clinical Pathway Facilitates Safe Next-Day Discharge Home at Low-, Medium-, and High-Volume Transfemoral Transcatheter Aortic Valve Replacement Centers: The 3M TAVR Study. JACC Cardiovasc Interv. 2019;12:459–469. https://doi.org/10.1016/j.jcin.2018.12.020. This prospective multicenter study demonstrated the feasibility and safety of a comprehensive minimalist approach with next-day discharge.

11.

Kotronias RA, Teitelbaum M, Webb JG, Mylotte D, Barbanti M, Wood DA, et al. Early Versus Standard Discharge After Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis. JACC Cardiovasc Interv. 2018;11:1759–71. https://doi.org/10.1016/j.jcin.2018.04.042.CrossRefPubMed

12.

Qureshi WT, Kundu A, Mir T, Khan A, Anwaruddin S, Sattar Y, et al. Meta-analysis of minimalist versus standard care approach for transcatheter aortic valve replacement. Expert Rev Cardiovasc Ther. 2021;19:565–74. https://doi.org/10.1080/14779072.2021.1920926.CrossRefPubMed

13.

Perdoncin E, Greenbaum AB, Grubb KJ, Babaliaros VC, Keegan P, Ceretto-Clark B, et al. Safety of same-day discharge after uncomplicated, minimalist transcatheter aortic valve replacement in the COVID-19 era. Catheter Cardiovasc Interv. 2021;97:940–7. https://doi.org/10.1002/ccd.29453.CrossRefPubMed

14.

Krishnaswamy A, Isogai T, Agrawal A, Shekhar S, Puri R, Reed GW, et al. Feasibility and Safety of Same-Day Discharge Following Transfemoral Transcatheter Aortic Valve Replacement. JACC Cardiovasc Interv. 2022;15:575–89. https://doi.org/10.1016/j.jcin.2022.01.013.CrossRefPubMed

15.

•• Barker M, Sathananthan J, Perdoncin E, Devireddy C, Keegan P, Grubb K, et al. Same-Day Discharge Post-Transcatheter Aortic Valve Replacement During the COVID-19 Pandemic: The Multicenter PROTECT TAVR Study. JACC Cardiovasc Interv. 2022;15:590–598. https://doi.org/10.1016/j.jcin.2021.12.046. Findings from this international prospective study demonstrated that same-day discharge post TAVR is safe in selected patients and showed similar rates of readmission compared to traditional TAVR.

16.

Kasel AM, Cassese S, Bleiziffer S, et al. Standardized imaging for aortic annular sizing: implications for transcatheter valve selection. JACC Cardiovasc Imaging. 2013;6:249–62.CrossRef

17.

Hahn RT, Nicoara A, Kapadia S, Svensson L, Martin R. Echocardiographic imaging for transcatheter aortic valve replacement. J Am Soc Echocardiogr. 2018;31:405–33.CrossRef

18.

Likosky DS, Marrin CA, Caplan LR, Baribeau YR, Morton JR, Weintraub RM, et al. Northern New England Cardiovascular Disease Study Group. Determination of etiologic mechanisms of strokes secondary to coronary artery bypass graft surgery. Stroke. 2003;34:2830–2834. https://doi.org/10.1161/01.STR.0000098650.12386.B3.

19.

Condado JF, Jensen HA, Maini A, Ko YA, Rajaei MH, Tsai LL, et al. Emory Structural Heart and Valve Center. Should We Perform Carotid Doppler Screening Before Surgical or Transcatheter Aortic Valve Replacement? Ann Thorac Surg. 2017;103:787–794. https://doi.org/10.1016/j.athoracsur.2016.06.076.

20.

Kochar A, Li Z, Harrison JK, Hughes GC, Thourani VH, Mack MJ, et al. Stroke and Cardiovascular Outcomes in Patients With Carotid Disease Undergoing Transcatheter Aortic Valve Replacement. Circ Cardiovasc Interv. 2018;11: e006322. https://doi.org/10.1161/CIRCINTERVENTIONS.117.006322.CrossRefPubMed

21.

Lateef N, Khan MS, Deo SV, Yamani N, Riaz H, Virk HUH, et al. Meta-Analysis Comparing Outcomes in Patients Undergoing Transcatheter Aortic Valve Implantation With Versus Without Percutaneous Coronary Intervention. Am J Cardiol. 2019;124:1757–64.CrossRef

22.

Patterson T, Clayton T, Dodd M, Khawaja Z, Morice MC, Wilson K, et al. ACTIVATION Trial Investigators. ACTIVATION (PercutAneous Coronary inTervention prIor to transcatheter aortic VAlve implantaTION): A Randomized Clinical Trial. JACC Cardiovasc Interv. 2021;14:1965–1974. https://doi.org/10.1016/j.jcin.2021.06.041.

23.

Thiele H, Kurz T, Feistritzer HJ, Stachel G, Hartung P, Eitel I, et al. Comparison of newer generation self-expandable vs. balloon-expandable valves in transcatheter aortic valve implantation: the randomized SOLVE-TAVI trial. Eur Heart J. 2020;41:1890–1899. https://doi.org/10.1093/eurheartj/ehaa036.

24.

Keegan P, Lisko J, Kamioka N, Maidman S, Binongo JN, Wei J, et al. Nurse Led Sedation: The Clinical and Echocardiographic Outcomes of the 5-Year Emory Experience. Structural Heart. 2020;4:302–9. https://doi.org/10.1080/24748706.2020.1773591.CrossRef

25.

Abdel-Wahab M, Landt M, Neumann FJ, Massberg S, Frerker C, Kurz T, et al. CHOICE Investigators. 5-Year Outcomes After TAVR With Balloon-Expandable Versus Self-Expanding Valves: Results From the CHOICE Randomized Clinical Trial. JACC Cardiovasc Interv. 2020;13:1071–1082. https://doi.org/10.1016/j.jcin.2019.12.026.

26.

Grubb K. Early OPTIMIZE PRO Data for Evolut Pro TAVR Systems Presentation. Society for Cardiovascular Angiography and Interventions. SCAI Virtual Sci Sessions. 2021.

27.

Lefèvre G, Jégou A, Dambrin G, Picard F, Anconina J, Pouzet B, et al. Comparison of TransFemoral Transcatheter Aortic Valve Replacement Performed With a Minimally Invasive Simplified Technique: "FAST" Versus a Standard Approach. J Invasive Cardiol. 2019;31:300–306.

28.

Barbanti M, van Mourik MS, Spence MS, et al. Optimising patient discharge management after transfemoral transcatheter aortic valve implantation: the multicentre European FAST-TAVI trial. EuroIntervention. 2019;15:147–54.CrossRef

29.

Ichibori Y, Li J, Davis A, et al. Feasibility and safety of adopting next-day discharge as first-line option after transfemoral transcatheter aortic valve replacement. J Invasive Cardiol. 2019;31:64–72.PubMed

30.

Di Mario C, Goodwin M, Ristalli F, Ravani M, Meucci F, Stolcova M, et al. A Prospective Registry of Intravascular Lithotripsy-Enabled Vascular Access for Transfemoral Transcatheter Aortic Valve Replacement. JACC Cardiovasc Interv. 2019;12:502–4. https://doi.org/10.1016/j.jcin.2019.01.211.CrossRefPubMed

31.

Oguri A, Yamamoto M, Mouillet G, Gilard M, Laskar M, Eltchaninoff H, et al. FRANCE 2 Registry Investigators. Clinical outcomes and safety of transfemoral aortic valve implantation under general versus local anesthesia: subanalysis of the French Aortic National CoreValve and Edwards 2 registry. Circ Cardiovasc Interv. 2014;7:602–10. https://doi.org/10.1161/CIRCINTERVENTIONS.113.000403.

32.

Sengupta PP, Wiley BM, Basnet S, Rajamanickman A, Kovacic JC, Fischer GW, et al. Transthoracic echocardiography guidance for TAVR under monitored anesthesia care. JACC Cardiovasc Imaging. 2015;8:379–80. https://doi.org/10.1016/j.jcmg.2015.01.002 (PMID: 25772842).CrossRefPubMed

33.

Harris M, Chung F. Complications of general anesthesia. Clin Plast Surg. 2013;40:503–13. https://doi.org/10.1016/j.cps.2013.07.001.CrossRefPubMed

34.

Babaliaros V, Devireddy C, Lerakis S, et al. Comparison of transfemoral transcatheter aortic valve replacement performed in the catheterization laboratory (minimalist approach) versus hybrid operating room (standard approach): outcomes and cost analysis. JACC Cardiovasc Interv. 2014;7:898–904.CrossRef

35.

Yerasi C, Tripathi B, Wang Y, Forrestal BJ, Case BC, Khan JM, et al. National trends and 30-day readmission rates for next-day-discharge transcatheter aortic valve replacement: An analysis from the Nationwide Readmissions Database, 2012–2016. Am Heart J. 2021;231:25–31. https://doi.org/10.1016/j.ahj.2020.08.015.CrossRefPubMed

36.

Muntané-Carol G, Okoh AK, Chen C, Nault I, Kassotis J, Mohammadi S, et al. Ambulatory Electrocardiographic Monitoring Following Minimalist Transcatheter Aortic Valve Replacement. JACC Cardiovasc Interv. 2021;14:2711–22. https://doi.org/10.1016/j.jcin.2021.08.039.CrossRefPubMed

37.

Lauck SB, Kwon JY, Wood DA, Baumbusch J, Norekvål TM, Htun N, et al. Avoidance of urinary catheterization to minimize in-hospital complications after transcatheter aortic valve implantation: An observational study. Eur J Cardiovasc Nurs. 2018;17:66–74. https://doi.org/10.1177/1474515117716590.CrossRefPubMed

38.

• Baron SJ, Wang K, House JA, Magnuson EA, Reynolds MR, Makkar R, et al. Cost-Effectiveness of Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Risk. Circulation. 2019;139:877–888. https://doi.org/10.1161/CIRCULATIONAHA.118.035236. This cost analysis study revealed that from a resource utilization and cost perspective, minimalist TAVR uses significantly less resources compared to traditional approaches.

39.

Cohen DJ. Economic outcomes of TAVR vs. SAVR for low-risk patients: results from the PARTNER 3 trial. TCT. 2021.

40.

Lampert J, Finn MT, Kantor A, Akkoc D, Chen S, Brandwein R, et al. Urologic Complications in Patients Receiving Indwelling Urinary Catheters During Transcatheter Aortic Valve Replacement. J Invasive Cardiol. 2020;32(7):269–74 (PMID: 32610268).PubMed

Title: Update on Minimalist TAVR Care Pathways: Approaches to Care in 2022
Authors: Mariem A. Sawan
Avery E. Calhoun
Kendra J. Grubb
Chandan M. Devireddy
Publication date: 29-06-2022
Publisher: Springer US
Keywords: Aortic Valve Replacement
Care
Aortic Valve Replacement
Aortic Valve Replacement
General Anesthesia
Published in: Current Cardiology Reports / Issue 9/2022
Print ISSN: 1523-3782
Electronic ISSN: 1534-3170
DOI: https://doi.org/10.1007/s11886-022-01737-x

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Update on Minimalist TAVR Care Pathways: Approaches to Care in 2022

Abstract

Purpose of Review

Recent Findings

Summary

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose of Review

Recent Findings

Summary

Please log in to get access to this content

Other articles of this Issue 9/2022

Advanced Echocardiographic Techniques in Cardio-Oncology: the Role for Early Detection of Cardiotoxicity

Keto is Trending: Implications for Body Weight and Lipid Management

Tricuspid Valve Percutaneous Therapies

HIV and Global Cardiovascular Health

Health Disparities Across the Continuum of ASCVD Risk

Disparities in Cardio-oncology: Effects On Outcomes and Opportunities for Improvement

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page